Form D · Other Health Care
Apollo Neuroscience, Inc.
Pittsburgh, PA · CIK 0001735427
Offering snapshot reported Apr 30, 2024 · SEC filing
- Reported sold
- $500K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 15, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 30, 2024 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Apr 29, 2024 | Amendment | $9,270,041 | $3,275,041vs Oct 12, 2023 | 17 | SEC filing |
| Oct 12, 2023 | Amendment | $5,995,000 | $4,945,000vs Feb 22, 2023 | 10 | SEC filing |
| Feb 22, 2023 | Initial | $1,050,000 | No comparison | 2 | SEC filing |
| Sep 30, 2021 | Amendment | $8,005,730 | $3,945,936vs May 25, 2021 | 17 | SEC filing |
| May 25, 2021 | Initial | $4,059,794 | No comparison | 12 | SEC filing |
| Feb 12, 2021 | Amendment | $5,890,100 | $1,835,000vs May 7, 2020 | 51 | SEC filing |
| May 7, 2020 | Amendment | $4,055,100 | $2,545,100vs Jul 3, 2018 | 46 | SEC filing |
| Jul 3, 2018 | Initial | $1,510,000 | No comparison | 8 | SEC filing |
| Mar 28, 2018 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-511993
Debt convertible into equity
Source: Form D, filed Apr 30, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Cannistraro | Director, Executive |
| Kathryn Fantauzzi | Director, Executive |
| Gary Johnson | Director |
| David Rabin | Director, Executive |
| Sa'ad Shah | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1942 Fifth Avenue
Pittsburgh, PA, 15219
Pittsburgh, PA, 15219